Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

10 Jun 2021 07:00

RNS Number : 4020B
Sopheon PLC
10 June 2021
 

SOPHEON PLC

 

("Sopheon" or the "Company")

 

AGM Statement

 

Sopheon, the international provider of software, expertise, and best practices for enterprise innovation management solutions, holds its Annual General Meeting ("AGM") today. Given the Coronavirus situation, Shareholders are not expected to attend the meeting in person, and were encouraged in the notice to submit a proxy vote. The Board takes this opportunity to give shareholders the following update and review of the business.

 

2020 in review

 

We were proud to report a growth in contractual bookings in a year of unpredictability and unparalleled disruption. Revenue at $30m matched 2019, showing resilience, and several transformational indicators showed rising commercial traction, even in the face of two separate headwinds - the pandemic introduced new challenges to sales and retention; and our strategy to make selling new SaaS contracts a priority. Transition to SaaS contracts reduces revenue recognition in the first year compared to traditional perpetual licenses, trading this for a higher quality and predictable ongoing recurring revenue stream in the future. In spite of these challenges, Total Contract Value (TCV) of sales booked in the year was up almost a quarter, and we nearly tripled the TCV of new SaaS contracts booked. Six of the new deals signed exceeded $1m in initial TCV, and Annual Recurring Revenue (ARR) closed at $18m, an historic high up from $15.9m a year ago. As always, much of this activity concentrated into the fourth quarter. Retention was impacted during the initial stages of the pandemic, then rebounded later in the year. We achieved this while delivering a solidly profitable and cash generative year, also reporting new highs in cash balances and closing net assets. In parallel, we embarked on the development of new cloud-native products, which will bring value to personal and workgroup productivity alongside the corporate value points we are well known for. In addition, in early 2021, we introduced new leadership with the appointment of Greg Coticchia as CEO, Andy Michuda moving to the executive chairman role with a particular focus on partnerships and acquisitions, and Barry Mence stepping back to become a non-executive director. Our dividend was maintained at 3.25p per share, and is proposed to shareholders in today's meeting.

 

Operational update

 

Since the start of the year, under Greg's leadership we have continued to execute on our transformational strategy. This is exemplified by the recent appointments of Mike Bauer as Chief Product Officer, John Beischer as Americas VP of Sales, and Ann Marie Beasley as Chief Marketing Officer. Each one of these appointees bring an impressive track record and their experience, creativity, and drive will be valuable assets to Sopheon during this exciting period of transformation and growth. Mike has introduced over 100 products to market in his career, and offers deep experience in creating cloud-based solutions working across a range of companies, from start up to established enterprise such as Avnet and 3Com. John has led transformation efforts at various companies, from emerging enterprises to industry powerhouses like IBM and has an impressive record of creating and expanding industry leading go-to-market distribution channels in competitive and complex marketplaces. Ann Marie boasts an exceptional track record for developing and executing successful marketing strategies at companies like Allscripts, CA Technologies and Symantec.

 

Another milestone was the launch of Accolade® for Smart Products, the first innovation management solution to bring together traditionally siloed software and physical product development - a new SaaS-based solution that enables companies to develop innovative digitally-enabled physical products in a new collaborative and efficient way with speed.

 

Outlook

 

We are pleased to report 27 software transactions closed so far this year, of which just under half were SaaS related. So far these have been mainly customer extension deals and smaller in size - metrics we expect to balance out through the year as normal with some new and larger deals in the pipeline. Customer retention has been strong; and coupled with new orders, ARR has risen above $19m compared to $18m at the end of 2020. Visibility for the full year 2021 now stands at $28m, compared to $23.2m at the time of our AGM announcement last year, which is very encouraging. In parallel with this continued evidence of commercial traction, we continue to see a strong appetite for innovation solutions. With our new senior appointments, we are undertaking a detailed review of our sales pipelines as companies work to find the new norm of conducting business post Covid. We are already seeing the benefits of alternative approaches and fresh ideas. Net cash at the end of May was $23.3m (2020: $21.3m), though a seasonal peak always occurs this time of year, it underlines our financial strength. These commercial and financial proof points give us the confidence to proceed with our strategy both in terms of operational expansion - we continue to hire and invest for growth - and with continuing our search of the right M&A candidates.

 

For further information contact:

 

Andy Michuda (Executive Chairman)Arif Karimjee (CFO)

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Edward Whiley (Corporate Finance)Alice Lane/Sunila da Silva (ECM)

finnCap Ltd

+ 44 (0) 20 7220 0500

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 250 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFVARAIAIIL
Date   Source Headline
21st Feb 20247:00 amRNSCancellation - Sopheon Plc
20th Feb 20244:31 pmRNSScheme of Arrangement becomes Effective
20th Feb 20247:30 amRNSSuspension - Sopheon plc
16th Feb 20241:40 pmRNSIssue of Equity, PDMR Dealing and Rule 2.9
16th Feb 20241:35 pmRNSCourt Sanction of Scheme of Arrangement
16th Feb 20249:04 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
14th Feb 20248:32 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20245:30 pmRNSSopheon
9th Feb 20243:30 pmRNSForm 8.3 - SPHN LN
9th Feb 20249:35 amRNSForm 8.3 - Sopheon plc
9th Feb 20249:14 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20242:00 pmRNSResults of Court Meeting and General Meeting
17th Jan 20241:31 pmRNSHolding(s) in Company
17th Jan 20249:42 amRNSForm 8.3 - Sopheon plc
16th Jan 20245:45 pmRNSPublication of Scheme Document
15th Jan 202410:53 amRNSForm 8.3 - Sopheon plc
15th Jan 20248:13 amRNSForm 8.3 - SOPHEON PLC
12th Jan 20243:22 pmRNSForm 8.3 - Sopheon PLC
11th Jan 20248:50 amRNSSatisfaction of NSIA Condition
11th Jan 20248:49 amRNSForm 8.3 - SOPHEON PLC
10th Jan 20249:13 amRNSForm 8.3 - SOPHEON PLC
9th Jan 202412:35 pmRNSForm 8.3 - Sopheon plc
9th Jan 20248:48 amRNSForm 8.3 - SOPHEON PLC
8th Jan 202412:22 pmRNSIssue of Equity
8th Jan 20248:31 amRNSForm 8.3 - SOPHEON PLC
4th Jan 20249:45 amRNSForm 8.3 - SOPHEON PLC
2nd Jan 20245:18 pmRNSForm 8.3 - Sopheon Plc
2nd Jan 20249:07 amRNSForm 8.3 - SOPHEON PLC
22nd Dec 20231:00 pmRNSRecommended Cash Offer
15th Dec 20238:39 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20238:32 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202310:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20238:37 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20238:36 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20239:16 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 20236:18 pmRNSRule 2.9 Announcement
4th Dec 202312:30 pmRNSIssue of Equity
28th Nov 20237:00 amRNSOffer update - extension to PUSU Deadline
17th Nov 202311:39 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:30 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20232:59 pmRNSForm 8.3 - SOPHEON PLC
10th Nov 202311:40 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 202311:09 amRNSForm 8.3 - Rivomore Limited - Sopheon plc - Amend
9th Nov 20239:15 amRNSForm 8.5 (EPT/NON-RI)
8th Nov 202312:57 pmRNSForm 8.3 - Sopheon plc
8th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
8th Nov 20237:00 amRNSForm 8 (OPD) Sopheon plc
7th Nov 202311:24 amRNSForm 8.5 (EPT/NON-RI)
6th Nov 20231:03 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.